Alliance for Clinical Trials in Oncology: Central Nervous System Neoplasms trials
The registry lists 12 Central Nervous System Neoplasms studies with Alliance for Clinical Trials in Oncology as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 3Phase 2 8Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00869401Phase 1/2Results posted
- Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00621686Phase 2Results posted
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT00553150Phase 1/2Results posted
- Study of Tissue and Blood Samples From Patients With High-Grade GliomaCompletedNCT01004887
- Study of Tissue and Blood Samples From Patients With Low-Grade GliomaCompletedNCT01004523
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor TherapiesCompletedNCT00897663
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade GliomaActive, not recruitingNCT00887146Phase 3
- Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma MultiformeCompletedNCT00027612Phase 1/2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00003996Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic AstrocytomaCompletedNCT00003621Phase 2
- Irinotecan in Treating Patients With Recurrent GliomaCompletedNCT00003134Phase 2
- Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial GliomaCompletedNCT00002806Phase 2